Artificial uterus

An artificial uterus (or womb) is a theoretical device that would allow for extracorporeal pregnancy or extrauterine fetal incubation (EUFI)[1] by growing an embryo or fetus outside of the body of a female organism that would normally internally carry the embryo or fetus to term.

An artificial uterus, as a replacement organ, could be used to assist women with damaged or diseased uteri to bring the fetus to term.[1] This can potentially be performed as a switch from a natural uterus to an artificial uterus, thereby moving the threshold of fetal viability to a much earlier stage of pregnancy.[1] In this sense, it can be regarded as a neonatal incubator with very extended functions. Also, it can potentially be used for initiation of fetal development.[1] Furthermore, it could avail for performing, for example, fetal surgery procedures at an early stage instead of having to postpone them until term of pregnancy.[1]

Contents

Components

An artificial uterus would have to provide nutrients and oxygen to nurture a fetus, as well as dispose of waste material. The scope of an artificial uterus (or "artificial uterus system" to emphasis a broader scope) may also include the interface serving the function otherwise provided by the placenta, an amniotic tank functioning as the amniotic sac, as well as an umbilical cord.

Nutrition and oxygen supply and waste disposal

A human may still supply nutrients and dispose of waste products if the artificial uterus is connected to her (or, potentially, him).[1] Also, it may provide immune protection against diseases by passing of IgG antibodies to the embryo or fetus.[1]

Artificial supply and disposal have the potential advantage of allowing the fetus to develop in an environment that is not influenced by the presence of disease, environmental pollutants, alcohol, or drugs which a human may have in the circulatory system.[1] Also, there is no risk of an immune reaction towards the embryo or fetus that could otherwise arise from insufficient gestational immune tolerance.[1] Following are aspects of individual functions of an artificial supplier and disposer:

Theoretically, animal suppliers and disposers may be used, but when involving an animal's uterus the technique may rather be in the scope of interspecific pregnancy.

Uterine wall

Naturally, the myometrium of the uterine wall functions to expel the fetus at the end of a pregnancy, and the endometrium plays a role in forming the placenta.

An artificial uterus may include components of equivalent function. Also, methods have been considered to connect an artificial placenta and other "inner" components directly to an external circulation.[1]

Interface (artificial placenta)

An interface between the supplier and the embryo or fetus may be entirely artificial, e.g. by using one or more semipermeable membranes such as is used in extracorporeal membrane oxygenation (ECMO).[2]

There is also potential to grow a placenta using human endometrial cells. In 2002, it was announced that tissue samples from cultured endometrial cells removed from a human donor had successfully grown.[6][7] The tissue sample was then engineered to form the shape of a natural uterus, and human embryos were then implanted into the tissue. The embryos correctly implanted into the artificial uterus' lining and started to grow. However, the experiments were halted after six days to stay within the permitted legal limits of in vitro fertilisation (IVF) legislation in the United States.[1]

Also, a human placenta may theoretically be transplanted to inside an artificial uterus, but the passage of nutrients across this artificial uterus remains an unsolved issue.[1]

Amniotic tank (artificial amniotic sac)

The main function of an amniotic tank would be to fill the function of the amniotic sac in physically protecting the embryo or fetus, optimally allowing it to move freely. It should also be able to maintain an optimal temperature. Lactated Ringer's solution can be used as a substitute for amniotic fluid.[2]

Umbilical cord

Theoretically, in case of premature removal of the fetus from the natural uterus, the natural umbilical cord could be used, kept open either by medical inhibition of physiological occlusion, by anti-coagulation as well as by stenting or creating a bypass for sustaining blood flow between the mother and fetus.[1]

Potential for controversy

There would be implications for the ongoing controversy regarding abortion, for example by potentially allowing a woman to terminate a pregnancy very prematurely without ending the life of the fetus. Although the technology does not currently exist to raise an embryo from conception to full development outside of a human body, the possibility of such technology raises questions with respect to cloning as well. The elimination of the need for a living uterus would make cloning easier to carry out and yet harder for legal authorities to track. At the same time, the capacity to raise an unwanted fetus apart from the mother would allow the option of fetus adoption, but might raise concerns with respect to children born with no connection to a parent. Some pro-life groups argue that this would allow a father to have a choice in whether to carry a pregnancy to term.

In fiction

The use of the artificial uterus has played a significant role in science fiction:

See also

References

  1. ^ a b c d e f g h i j k l m n o p q r Bulletti, C.; Palagiano, A.; Pace, C.; Cerni, A.; Borini, A.; De Ziegler, D. (2011). "The artificial womb". Annals of the New York Academy of Sciences 1221: 124–128. doi:10.1111/j.1749-6632.2011.05999.x. PMID 21401640.  edit
  2. ^ a b c Sakata M, Hisano K, Okada M, Yasufuku M (May 1998). "A new artificial placenta with a centrifugal pump: long-term total extrauterine support of goat fetuses". J. Thorac. Cardiovasc. Surg. 115 (5): 1023–31. PMID 9605071. 
  3. ^ Bautista-Hernandez, V.; Thiagarajan, R. R.; Fynn-Thompson, F.; Rajagopal, S. K.; Nento, D. E.; Yarlagadda, V.; Teele, S. A.; Allan, C. K. et al. (2009). "Preoperative Extracorporeal Membrane Oxygenation as a Bridge to Cardiac Surgery in Children with Congenital Heart Disease". The Annals of Thoracic Surgery 88 (4): 1306–1311. doi:10.1016/j.athoracsur.2009.06.074. PMID 19766826.  edit
  4. ^ Alan H. Jobe, MD, PhD. Post-conceptional age and IVH in ECMO patients. RadiologySource Volume 145, Issue 2, Page A2 (August 2004). PII: S0022-3476(04)00583-9. doi:10.1016/j.jpeds.2004.07.010.
  5. ^ Spencer AU, Neaga A, West B, et al. (September 2005). "Pediatric short bowel syndrome: redefining predictors of success". Ann. Surg. 242 (3): 403–9; discussion 409–12. PMC 1357748. PMID 16135926. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1357748.  (mean follow-up time was 5.1 years)
  6. ^ IVF.org - Center for Reproductive Medicine and Infertility, New York, NY
  7. ^ Weill Cornell Research
  8. ^ Development of an Artificial Placenta Nobuya Unno. Year 2000

External links